Topics

IONTAS and Adaptate Biotherapeutics Collaborate to Identify Optimised Antibodies for Novel Cancer Targets

05:34 EST 3 Dec 2019 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
  IONTAS Limited (IONTAS), a leader in the discovery and optimisation of fully human antibodies, today announced it has entered into a collaboration agreement with Adaptate Biotherapeutics, developers of antibody-based therapeutics for modulation of gam...

Other Sources for this Article

Zyme Communications
Lily Jeffery
Tel: +44(0)7891 477 378
lily.jeffery@zymecommunications.com

NEXT ARTICLE

More From BioPortfolio on "IONTAS and Adaptate Biotherapeutics Collaborate to Identify Optimised Antibodies for Novel Cancer Targets"

Quick Search

Relevant Topics

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...